Clover Health Investments, Corp. (CLOV)

NASDAQ

$2.62

-$0.08 (3.15%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$2.61$2.74

Open $2.72

52 Week Range

$2.12$4.87

Previous Close $2.70

Market Cap1.35B

Volume4.36M

Avg Volume8.78M

P/E (TTM)-22.99

EPS (TTM)$-0.11

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$3.00

Based on 2 analysts (last year)

High Target

$3.00

Low Target

$3.00

Potential upside of 14.72%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$3.00

1 analysts

Last Year

$4.50

2 analysts

All Time

$3.33

4 analysts

Analyst Consensus

Current Consensus

Hold

Based on 8 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

D+

(Score: 1)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity1/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share2/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Oct 21, 2025	Whit Mayo	Leerink Partners	$3.00	$2.92	+2.74%
Dec 17, 2024	Matt Hewitt	Craig-Hallum	$6.00	$3.16	+89.90%
Aug 6, 2024	Richard Close	Canaccord Genuity	$2.50	$1.86	+34.32%
Nov 16, 2022	Unknown	Citigroup	$1.80	$1.44

Recent Analyst Actions


Nov 6, 2025	Maintained	Canaccord Genuity	Buy	Buy
Aug 7, 2025	Maintained	Canaccord Genuity	Buy	Buy
Aug 6, 2025	Maintained	UBS	Neutral	Neutral
Mar 3, 2025	Maintained	Canaccord Genuity	Buy	Buy
Aug 11, 2023	Maintained	Citigroup	Neutral	Neutral

Showing 1 to 5 of 36 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$3.00

Based on 2 analysts (last year)

High Target

$3.00

Low Target

$3.00

Potential upside of 14.72%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$3.00

1 analysts

Last Year

$4.50

2 analysts

All Time

$3.33

4 analysts

Analyst Consensus

Current Consensus

Hold

Based on 8 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

D+

(Score: 1)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity1/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share2/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Oct 21, 2025	Whit Mayo	Leerink Partners	$3.00	$2.92	+2.74%
Dec 17, 2024	Matt Hewitt	Craig-Hallum	$6.00	$3.16	+89.90%
Aug 6, 2024	Richard Close	Canaccord Genuity	$2.50	$1.86	+34.32%
Nov 16, 2022	Unknown	Citigroup	$1.80	$1.44

Recent Analyst Actions


Nov 6, 2025	Maintained	Canaccord Genuity	Buy	Buy
Aug 7, 2025	Maintained	Canaccord Genuity	Buy	Buy
Aug 6, 2025	Maintained	UBS	Neutral	Neutral
Mar 3, 2025	Maintained	Canaccord Genuity	Buy	Buy
Aug 11, 2023	Maintained	Citigroup	Neutral	Neutral

Showing 1 to 5 of 36 entries